1-4 of 4
Hans Vos
Close
Sort by
Journal Articles

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Wouter Plattel, MD, Anke Van Den Berg, PhD, Anne Marijn Van der Graaf, Hans Vos, Lydia Visser, PhD, Arjan Diepstra, MD, PhD, Gustaaf van Imhoff, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 748.
https://doi.org/10.1182/blood.V116.21.748.748
Published: 2010
Journal Articles

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Huang Xin, MD, Arjan Diepstra, MD, PhD, Zifen Gao, MD, PhD, Lydia Visser, PhD, Hans Vos, Wierd Kooistra, Sibrand Poppema, MD, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD
Journal: Blood
Blood (2010) 116 (21): 2688.
https://doi.org/10.1182/blood.V116.21.2688.2688
Published: 2010
Journal Articles

Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

Yue Ma, Lydia Visser, Han Roelofsen, Marcel de Vries, Arjan Diepstra, Gustaaf van Imhoff, Tineke van der Wal, Marjan Luinge, Gloria Alvarez-Llamas, Hans Vos, Sibrand Poppema, Roel Vonk, Anke van den Berg
Journal: Blood
Blood (2008) 111 (4): 2339–2346.
https://doi.org/10.1182/blood-2007-09-112128
Published: 2008
Includes: Supplemental data
Journal Articles

Discovery of Biomarkers for Hodgkin Lymphoma Using Proteomics Technology.

Yue Ma, Han Roelofsen, PhD, Lydia Visser, PhD, Marcel de Vries, Gloria Alvarez-Llamas, PhD, Hans Vos, Roel Vonk, PhD, Sibrand Poppema, MD. PhD, Anke van den Berg, PhD
Journal: Blood
Blood (2006) 108 (11): 2261.
https://doi.org/10.1182/blood.V108.11.2261.2261
Published: 2006